Incyte Corp
INCY
NASDAQ
Biotechnology
$120.16
USD
-0.36 (-0.30%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $24.41B
Volume 785.7K
Price Target
$99.00 – $155.00
USD
The 7 analysts offering 1-year price forecasts have a max estimate of $155.00 and a min estimate of $99.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$124.00
+$15.0 vs prior
Implied Upside
+3.2%
+12.5% vs prior
Analyst Covering
7
Unchanged vs prior period
Consensus
Hold
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$11 Gap
Median $113.00 vs avg $124.00 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
3 Buy
4 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
4
Sell
0
Strong Sell
0
7 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Mitchell S. Kapoor | HC Wainwright & Co. | Buy | Reiterated | 1 week ago | Plus | Plus | Plus |
Andrew Berens | Leerink Partners | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Etzer Darout | BMO Capital | Buy | Maintained | 4 weeks ago | Plus | Plus | Plus |
Evan Seigerman | BMO Capital | Hold | Maintained | 4 weeks ago | Plus | Plus | Plus |
Ashwani Verma | UBS | Hold | Maintained | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
RVMD
Revolution Medicines Inc
$203.71
▲ +0.8%
NBIX
Neurocrine Biosciences Inc
$152.72
▲ +1.3%
UTHR
United Therapeutics Corp
$499.73
▼ -0.3%
BIIB
Biogen Inc
$209.83
▼ -0.4%
BMRN
BioMarin Pharmaceutical Inc
$67.36
▼ -1.7%
ALNY
Alnylam Pharmaceuticals Inc
$228.65
▲ +0.7%
BBIO
BridgeBio Pharma Inc
$79.86
▼ -1.7%
MRNA
Moderna Inc
$63.32
▼ -0.5%
EXEL
Exelixis Inc
$51.24
▲ +1.2%
INSM
Insmed Inc
$123.74
▼ -2.0%